Bara’a supports decision-makers in pharmaceutical companies with immediate, precise, and intelligent patent landscape analysis indicating business opportunities and threats associated with pharmaceutical patent issues.
Patent landscape analysis, including freedom to operate (FTO) report and/or infringing report (IR) in all designated territories, enable decision-makers in pharmaceutical companies to design their business case accordingly to the patent constraints that may affect their launching and commercializing plans in all targeted markets.
Bara’a expertise are devoted to helping their clients understand the IP language associated with such a heavily patented industry by providing a state-of-the-art patent landscape report and educating their clients on the IP terminology applied in the pharma industry.
Bara’a for pharmaceutical patent consultation expertise, covering all drug products dosage forms, including tablets, capsules, combinations, injectables, and biosimilar devices.
Bara’a team is highly flexible in tailoring our IP knowledge and experiences to meet the particular needs of our clients, including two models:
Case-by-case Consultation Business Model and One-year Consultation Business Model
Bara’a team is keen to assist clients in the IP department building capacity and lead the IP education and training sessions to enrich the IP knowledge level of clients’ employees during the agreement term.
